Driehaus Capital Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Driehaus Capital Management’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-285,687	Closed	-$4.8M	–	625
2017 Q3	$4.8M	Buy	+285,687	New	+$4.65M	0.19%	147
2015 Q1	–	Sell	-120,585	Closed	-$1.64M	–	579
2014 Q4	$1.64M	Sell	120,585 -26,345	-18%	-$360K	0.07%	346
2014 Q3	$2.24M	Sell	146,930 -2,538	-2%	-$38.9K	0.09%	297
2014 Q2	$2.52M	Sell	149,468 -35,449	-19%	-$638K	0.08%	306
2014 Q1	$3.71M	Buy	184,917 +81,894	+79%	+$1.77M	0.12%	223
2013 Q4	$2M	Buy	+103,023	New	+$1.82M	0.07%	315

Other funds holding OXFD

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Driehaus Capital Management's OXFD Position: Q4 2017 in Review

Driehaus Capital Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2017, closing a stake of 285,687 shares — an estimated $4.8M sold.

Driehaus Capital Management first reported a position in OXFD in Q4 2013 and held it in 6 quarters. The position peaked at $4.8M in Q3 2017. 77 funds tracked by Wall St. Rank hold OXFD as of Q4 2017.

Driehaus Capital Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2017 after selling out during the quarter.
Driehaus Capital Management sold 285,687 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2017, an estimated $4.8M.
Driehaus Capital Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and held it in 6 quarters.
Driehaus Capital Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $4.8M in Q3 2017.
77 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2017.

Based on Driehaus Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.